More NewsRead More
Hemispherx Amends and Restates Agreement with myTomorrows for the Early Access Program for Rintatolimod in Europe
May 23, 2016
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2016
May 16, 2016
Hemispherx Biopharma Announces Conference Call to Provide Quarterly Business Update on May 17, 2016
May 12, 2016
Hemispherx Biopharma Retains Huron Consulting Group to Support Partnering Strategy and Planning for Alferon® and Ampligen®
April 20, 2016
Hemispherx Biopharma Enters into Alfa-n3 Interferon Clinical Trial, Sales, Marketing, Distribution, and Supply Agreement with Saudi Arabia’s Premier Pharma Company in Fight Against the Deadly MERS Dis
April 04, 2016
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2015
March 29, 2016
Hemispherx Biopharma Announces Conference Call to Discuss Management Changes and Provide Corporate Update on March 30, 2016
March 22, 2016
Hemispherx Biopharma Reviews Ampligen® Data With National Institute of Neurological Disorders and Stroke (NINDS)
March 10, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here